Signup Crypto ETF Stocks News

Why Novo Nordisk Stock Eked Out a Win on Monday

Wegovy and Ozempic maker Novo Nordisk ( NYSE: NVO ) saw its stock price tick up slightly on Monday, on a media report about the possible entry of an activist investor. Market players cautiously bid the shares a little more than 1% higher on the news.

Source: www.fool.com
June 09, 2025 | 22:49:12
Category: News

Tractor Supply: A Strong Performer in a Challenging Retail Landscape

Explore the exciting world of Tractor Supply ( NASDAQ: TSCO ) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of April 30, 2025.

Source: www.fool.com
June 09, 2025 | 23:00:00
Category: News

Avista reaches all-party, all issues settlement in Idaho general rate cases

If approved, new rates would take effect beginning Sept. 2025 and Sept. 2026 If approved, new rates would take effect beginning Sept. 2025 and Sept. ...

Source: www.globenewswire.com
June 09, 2025 | 23:21:00
Category: News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW and HLGN on Behalf of Shareholders - Know Labs ( AMEX:KNW ) , Heliogen ( OTC:HLGN )

NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Know Labs, Inc.

Source: www.benzinga.com
June 09, 2025 | 23:23:49
Category: News

Thirteen Studies of Ascentage Pharma's Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma ( NASDAQ: AAPG. HKEX: 6855 ) , a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - including the novel drug olverembatinib ( ...

Source: www.globenewswire.com
June 09, 2025 | 23:30:00
Category: News

Chinese stocks 'not particularly cheap' with weak earnings power, JPMorgan says

Chinese equities are not as cheap as they seem because the nation's economic slowdown has weakened corporate earnings, making it imperative for investors to screen stocks and sectors carefully to pick winners, according to JPMorgan Asset Management.

Source: www.scmp.com
June 09, 2025 | 23:30:07
Category: Money

Here's How Much You Would Have Made Owning Carpenter Tech Stock In The Last 20 Years - Carpenter Tech ( NYSE:CRS )

Carpenter Tech CRS has outperformed the market over the past 20 years by 3.15% on an annualized basis producing an average annual return of 11.46%. Currently, Carpenter Tech has a market capitalization of $12.60 billion.

Source: www.benzinga.com
June 09, 2025 | 23:30:15
Category: Trading

Thirteen Studies of Ascentage Pharma's Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress - Ascentage Pharma Group ( NASDAQ:AAPG )

ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma AAPG HKEX: 6855 ) ) , a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - including the novel drug olverembatinib ( HQP1351 ...

Source: www.benzinga.com
June 09, 2025 | 23:30:42
Category: News

Lido Merger Sub, Inc. Announces Extension of Expiration Date of Tender Offer and Consent Solicitation for 8.875% Senior Notes due 2029 of Landsea Homes Corporation

NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- Lido Merger Sub, Inc. ( the "Company" ) announced today that it is extending the Expiration Date ( as defined below ) of its previously announced cash tender offer ( the "Tender Offer" ) to purchase any and all of Landsea Homes Corporation's ( ...

Source: www.benzinga.com
June 09, 2025 | 23:30:46
Category: Markets

Crypto exec ran a 'covert pipeline for dirty money,' DOJ says

Evita Pay founder Iurii Gugnin has been accused of using sanctioned Russian banks to launder millions into the US, with the funds used in part to undermine American interests.

Source: cointelegraph.com
June 09, 2025 | 23:38:45
Category: News

© Natavest 2025 - 2026